Maintain a normothermic temperature In patients it is usually a challenge. The hipotermia accidental It is a known risk that can lead to further complications and prolonged hospital stays. A key factor contributing to accidental hypothermia is the infusion of cold blood and intravenous fluids.
Research has shown that the infusion of one liter of saline solution at room temperature can reduce body temperature of an adult by 0.4 degrees Celsius, while normothermic fluids do not have this effect. Therefore, infusion of blood and warm fluids is crucial to reduce the incidence of accidental hypothermia. Now, a revolutionary system allows the administration Fast, easy and efficient warm-blooded and intravenous fluids to patients.
This system features a portable, easy-to-use design that makes it easy to warm blood and intravenous fluids anywhere.
The heating system °M Warmer the °MEQU (Copenhagen, Denmark) presents a Portable and easy to use design which facilitates warming of blood and intravenous fluids anywhere, whether at the site of an injury, in transit or within a hospital environment, thereby minimizing the risk of hypothermia in patients prone to bleeding.
Using a patented heating technologythe °M Warmer can warm intravenous fluids, including blood, from cold to body temperature in less than 10 seconds. The system also supports a high and constant normothermic flow up to 150 ml/min. Features a unique adhesive fixation mechanism that secures the warmer close to the infusion site, significantly minimizing any heat loss. This proximity and fixation substantially reduces the potential for intravenous access issues.
“Receiving FDA approval is an important milestone”
Setting up the heating system is simple and quick, It takes less than 30 seconds and features safety measures to prevent assembly errors during stressful conditions. The °M Warmer stands out as the smallest and most compact system available, making it especially suitable for use in busy treatment areas and for easy transport at the patient’s side. Its design features a minimal priming volume of only 3.5 mL, ensuring that no blood or valuable fluids are wasted. The warmer system is also maintenance-free and designed with smooth surfaces for easy cleaning. MEQU has obtained 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for military and civilian use.
“We are proud to receive FDA approval, which is an important milestone for our company and the result of more than 10 years of product development“said Ulrik Krogh Andersen, Founder and CEO of °MEQU. “With the authorization, the path is paved for a strong presence in the US market and we are honored to be able to support US healthcare professionals in their life-saving efforts with our °M Warmer System.”
The content of ConSalud is prepared by journalists specialising in health and endorsed by a committee of top-level experts. However, we recommend that readers consult a healthcare professional for any health-related questions.
